{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:27:56Z","timestamp":1788956876461,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Ethiopia has set a goal to eliminate malaria by 2030; Artemether\u2013lumefantrine (AL) is put as one of the cornerstone strategies for uncomplicated<jats:italic>plasmodium falciparum<\/jats:italic>malaria treatment. However, only focusing on prescribing of the treatment without assessing patients\u2019 adherence could lead to the resistance of the drug. In Ethiopia, there is limited evidence about patients\u2019 adherence to AL and its influencing factors. Therefore, this study aimed at addressing this information gap.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A health facility based cross-sectional study was employed. Participants were selected using simple random sampling technique from registration books of the public health facilities in AsgedeTsimbla. Data were collected from March 24th to April 30th, 2018. We interviewed participants using a pre-tested structured questionnaire, and the blister pack was also inspected at their homes on day 4. Data were entered into Epi-Info and analyzed using SPSS 21. Odds ratios with 95% Confidence Intervals were estimated and the level of significance was declared at p-value\u2009\u2264\u20090.05.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 384 study participants were interviewed with a response rate of 95.5%. The overall AL adherence was 53.6% (95% CI 48.4\u201358.3%). Children aged\u2009&lt;\u20095\u00a0years [AOR: 0.4, 95% CI (0.2\u20130.8)], and being treated in health post [AOR: 0.3, 95% CI (0.1\u20130.5)] were more likely to show AL adherence whereas illiteracy [AOR: 9.4, 95% CI (4.2\u201321.3)], didn\u2019t know the consequence of discontinued AL [AOR: 4.0, 95% CI (2.1\u20137.6)], had concomitant drugs [AOR: 2.5, 95% CI (1.4\u20134.5)], and stopped\/saved drug when improved before tablet got finished [AOR: 3.2, 95% CI (1.7\u20135.9)] were factors less likely to be associated with AL adherence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>AL adherence was low. Children aged\u2009&lt;\u20095\u00a0years, and being treated in health post were determinants of AL adherence whereas illiteracy, didn\u2019t know the consequence of discontinued the drug, had concomitant drugs, and stopped\/saved drug when improved before tablet got finished were factors that hindered the AL adherence. Stakeholders should emphasize designing appropriate strategies including educational interventions to increase the AL adherence and prevent drug resistance. Further research should be conducted to evaluate AL resistance.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13756-020-00846-y","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T03:02:33Z","timestamp":1604977353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Artemether\u2013lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study"],"prefix":"10.1186","volume":"9","author":[{"given":"Mekonnen Gebremichael","family":"Gebrekidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebretsadik Berhe","family":"Gebremedhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef Sibhatu","family":"Gebregiorgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alefech Addisu","family":"Gezehegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kissanet Tesfay","family":"Weldearegay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"846_CR1","unstructured":"World Health Organization. \u201cAntimalarial drug combination therapy. Report of a WHOtechnical consultation,\u201dWHO\/CDS\/RBM 2001. Geneva, Switzerland; 2001."},{"key":"846_CR2","unstructured":"World Health Organization. World Malaria Report 2017; available from https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2017\/report\/en\/. Accessed 28 December, 2018. World Health Organization. 2017. 196 p."},{"key":"846_CR3","unstructured":"World Health Organization. WHO | Guidelines for the treatment of malaria. Third edition. WHO. 2015."},{"key":"846_CR4","volume-title":"Malaria case management training manual for health professionals in Ethiopia","author":"Ethiopian Federal Minstry of Health","year":"2016","unstructured":"Ethiopian Federal Minstry of Health. Malaria case management training manual for health professionals in Ethiopia. Addis Ababa, Federal Minstry of Health: Participants Manual; 2016."},{"key":"846_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.4269\/ajtmh.14-0126","volume":"91","author":"K Bruxvoort","year":"2014","unstructured":"Bruxvoort K, Festo C, Kalolella A, Cairns M, Lyaruu P, Kenani M, Kachur SP, Goodman CSD. Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing Artemether\u2013lumefantrine: Effect on dispenser knowledge and patient adherence. Am J Trop Med Hyg. 2014;91:844.","journal-title":"Am J Trop Med Hyg"},{"key":"846_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s40249-017-0372-5","volume":"6","author":"MB Ayalew","year":"2017","unstructured":"Ayalew MB. Therapeutic efficacy of Artemether\u2013lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: A systematic review and meta-analysis. Inf Dis Poverty. 2017;6:157.","journal-title":"Inf Dis Poverty."},{"key":"846_CR7","doi-asserted-by":"publisher","first-page":"84555","DOI":"10.1371\/journal.pone.0084555","volume":"9","author":"K Bruxvoort","year":"2014","unstructured":"Bruxvoort K, Goodman C, Patrick Kachur S, Schellenberg D. How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs. PLoS ONE. 2014;9:84555.","journal-title":"PLoS ONE"},{"key":"846_CR8","first-page":"123","volume":"2","author":"PE Anyanwu","year":"2016","unstructured":"Anyanwu PE, Fulton J. Socioeconomic determinants of antimalarial drug use behaviours: a systematic review. J Commun Public Heal Nurs. 2016;2:123.","journal-title":"J Commun Public Heal Nurs"},{"key":"846_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s41182-018-0125-6","volume-title":"Patients\u2019 adherence to artemisinin-based combination therapy and healthcare workers\u2019 perception and practice in Savannakhet province","author":"E Takahashi","year":"2018","unstructured":"Takahashi E, Nonaka D, Iwagami M, Phoutnalong V, Chanthakoumane K, Kobayashi J, et al. Patients\u2019 adherence to artemisinin-based combination therapy and healthcare workers\u2019 perception and practice in Savannakhet province. Trop Med Health: Lao PDR; 2018."},{"key":"846_CR10","first-page":"129","volume":"42","author":"JO Ogolla","year":"2013","unstructured":"Ogolla JO, Ayaya SO, Otieno CA. Levels of adherence to coartem\u00a9 in the routine treatment of uncomplicated malaria in children aged below five years, in Kenya. Iran J Public Health. 2013;42:129.","journal-title":"Iran J Public Health."},{"key":"846_CR11","doi-asserted-by":"crossref","unstructured":"Kalyango JN, Rutebemberwa E, Karamagi C, Mworozi E, Ssali S, Alfven T, et al. High Adherence to Antimalarials and Antibiotics under Integrated Community Case Management of Illness in Children Less than Five Years in Eastern Uganda. PLoS One. 2013.","DOI":"10.1371\/journal.pone.0060481"},{"key":"846_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-349","volume-title":"Adherence to a six-dose regimen of Artemether\u2013lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region","author":"H Lemma","year":"2011","unstructured":"Lemma H, L\u00f6fgren C, San SM. Adherence to a six-dose regimen of Artemether\u2013lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region. Malar J: Ethiopia; 2011."},{"key":"846_CR13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/cid\/cir498","volume":"53","author":"KE MacE","year":"2011","unstructured":"MacE KE, Mwandama D, Jafali J, Luka M, Filler SJ, Sande J, et al. Adherence to treatment with Artemether\u2013lumefantrine for uncomplicated Malaria in Rural Malawi. Clin Infect Dis. 2011;53:772.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"846_CR14","first-page":"16","volume":"4","author":"W Aung","year":"2015","unstructured":"Aung W, Dondorp AM, Min M, Kyaw TT, Lawpoolsri S, Krudsood SSP. Assessment of adherence to three days course of Artemether\u2013lumefantrine treatment in Rakhine state, Myanmar. JITMM Proc. 2015;4(3):16\u201323.","journal-title":"JITMM Proc"},{"key":"846_CR15","first-page":"525","volume":"71","author":"C Fogg","year":"2004","unstructured":"Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, Namiiro P, Musabe J, Kyomugisha A, Guthmann JP. Adherence to a six-dose regimen of Artemether\u2013lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J. 2004;71:525.","journal-title":"Am J"},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1475-2875-11-83","volume":"11","author":"JL Cohen","year":"2012","unstructured":"Cohen JL, Yavuz E, Morris A, Arkedis J, Sabot O. Do patients adhere to over-the-counter artemisinin combination therapy for malaria? Evidence from an intervention study in Uganda. Malar J. 2012;11:83.","journal-title":"Malar J."},{"key":"846_CR17","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20174552","volume-title":"Patients\u2019 adherence to antimalarial medication; self-report of patients at the Volta regional hospital of Ho","author":"A Afaya","year":"2017","unstructured":"Afaya A, Salia SM, Opare FY, Ali S, Afaya RA. Patients\u2019 adherence to antimalarial medication; self-report of patients at the Volta regional hospital of Ho. Int J Res Med Sci: Ghana; 2017."},{"key":"846_CR18","first-page":"452539","volume":"2015","author":"AO Amponsah","year":"2015","unstructured":"Amponsah AO, Vosper H, Marfo AF. Patient related factors affecting adherence to antimalarial medication in an urban estate in Ghana. Mal Res Treat . 2015;2015:452539.","journal-title":"Mal Res Treat"},{"key":"846_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2334-12-143","volume":"12","author":"EO Onyango","year":"2012","unstructured":"Onyango EO, Ayodo G, Watsierah CA, Were T, Okumu W, Anyona SB, et al. Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya. BMC Infect Dis. 2012;12:143.","journal-title":"BMC Infect Dis."},{"key":"846_CR20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2003.01157.x","volume-title":"Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement","author":"E Depoortere","year":"2004","unstructured":"Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, Balkan S, et al. Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement. Trop Med Int Heal: Zambia; 2004."},{"key":"846_CR21","doi-asserted-by":"crossref","unstructured":"Siddiqui MR, Willis A, Bil K, Singh J, Mukomena Sompwe E, Ariti C. Adherence to Artemisinin Combination Therapy for the treatment of uncomplicated malaria in the Democratic Republic of the Congo. F1000Research. 2015.","DOI":"10.12688\/f1000research.6122.1"},{"key":"846_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1475-2875-13-7","volume":"13","author":"K Banek","year":"2014","unstructured":"Banek K, Lalani M, Staedke SG, Chandramohan D. Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence. Malar J. 2014;13:7.","journal-title":"Malar J"},{"key":"846_CR23","doi-asserted-by":"crossref","unstructured":"Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clinic Proceedings. 2011.","DOI":"10.4016\/27949.01"},{"key":"846_CR24","volume-title":"Adherence to antimalarial treatments in the real world","author":"Medicines for Malaria Venture","year":"2015","unstructured":"Medicines for Malaria Venture. Adherence to antimalarial treatments in the real world. Medicines for malaria venture: African health journal; 2015."},{"key":"846_CR25","doi-asserted-by":"crossref","unstructured":"Lam WY, Fresco P. Medication adherence measures: an overview. BioMed research international. 2015.","DOI":"10.1155\/2015\/217047"},{"key":"846_CR26","unstructured":"World Health Organization. Guidelines for the treatment of malaria. 313 p."},{"key":"846_CR27","doi-asserted-by":"crossref","unstructured":"Huijben S. Experimental studies on the ecology and evolution of drug-resistant malaria parasites, 2010 available from https:\/\/www.era.lib.ed.ac.uk\/handle\/1842\/3945. Accessed 19 December 2017.","DOI":"10.1111\/j.1558-5646.2010.01068.x"},{"key":"846_CR28","first-page":"391","volume":"82","author":"D Jima","year":"2005","unstructured":"Jima D, Tesfaye G, Medhin A, Kebede A, Argaw D, Babaniyi O. Efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in ethiopia. East Afr Med J. 2005;82:391.","journal-title":"East Afr Med J."},{"key":"846_CR29","volume-title":"AsgedeTsimbla district health office: Endabaguna town","author":"AH Office","year":"2017","unstructured":"Office AH, Tsimbla A, district health report, . AsgedeTsimbla district health office: Endabaguna town. Ethiopia: Tigray; 2017."},{"key":"846_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LWLD. Concurrent and predictive validity of a self-reported measure of medication adherence: Morisky 8-Item Medication Adherence Questionnaire. Med Care. 1986;24:64.","journal-title":"Med Care."},{"key":"846_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4269\/ajtmh.2004.71.179","volume":"71","author":"S Yeung","year":"2004","unstructured":"Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ, White NJ. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am J Trop Med Hyg. 2004;71:179.","journal-title":"Am J Trop Med Hyg"},{"key":"846_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12936-015-0645-z","volume":"14","author":"GR Gore-Langton","year":"2015","unstructured":"Gore-Langton GR, Alenwi N, Mungai J, Erupe NI, Eves K, Kimwana FN, et al. Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting. Malar J. 2015;14:125.","journal-title":"Malar J."},{"key":"846_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12936-015-0602-x","volume":"14","author":"K Bruxvoort","year":"2015","unstructured":"Bruxvoort K, Kalolella A, Cairns M, Festo C, Kenani M, Lyaruu P, et al. Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy? Malar J. 2015;14:87.","journal-title":"Malar J."},{"key":"846_CR34","volume-title":"Methods of assessing and improving compliance in clinical trials. Patient compliance in medical practice and clinical trials","author":"B Spilker","year":"1991","unstructured":"Spilker B. Methods of assessing and improving compliance in clinical trials. Patient compliance in medical practice and clinical trials. New York: Ravan Press; 1991."},{"key":"846_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/1475-2875-10-369","volume":"10","author":"Q Bassat","year":"2011","unstructured":"Bassat Q, Gonz\u00e1lez R, MacHevo S, Nahum A, Lyimo J, Maiga H, et al. Similar efficacy and safety of Artemether\u2013lumefantrine (Coartem\u00ae) in African infants and children with uncomplicated falciparum malaria across different body weight ranges. Malar J. 2011;10:369.","journal-title":"Malar J."},{"key":"846_CR36","unstructured":"Definition of adherence: https:\/\/www.merckmanuals.com\/home\/drugs\/factors-affecting-response-to-drugs\/adherence-to-drug-treatment#v31787663. Accesed 30 January, 2018."},{"key":"846_CR37","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/cid\/cir498","volume":"53","author":"KE Mace","year":"2011","unstructured":"Mace KE, Mwandama D, Jafali J, Luka M, Filler SJ, Sande J, Ali D, Kachur SP, Mathanga DP, Skarbinski J. Adherence to treatment with artemetherlumefantrine for uncomplicated malaria in rural Malawi. Clin Infect Dis. 2011;53:772\u20139.","journal-title":"Clin Infect Dis"},{"key":"846_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/1475-2875-13-267","volume":"13","author":"O Minzi","year":"2014","unstructured":"Minzi O, Maige S, Sasi P, Ngasala B. Adherence to Artemether\u2013lumefantrine drug combination: a rural community experience six years after change of malaria treatment policy in Tanzania. Malar J. 2014;13:267.","journal-title":"Malar J."},{"key":"846_CR39","first-page":"CD005965","volume":"2006","author":"AA Omari","year":"2006","unstructured":"Omari AA, Gamble CL, Garner P. Artemether\u2013lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria. Cochrane Database Syst Rev. 2006;2006:CD005965.","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00846-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13756-020-00846-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00846-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T12:25:59Z","timestamp":1669551959000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-020-00846-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1186\/s13756-020-00846-y","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the ethical review board of the College of health sciences of Mekelle University. We obtained written informed consent from the adult study participants in each household. Assent was also obtained from participants younger than 18\u00a0years of age. During the tracing day, patients who were found still sick were immediately referred to the closest health facility. Patients\u2019 name was not written on the questionnaire, and all personal information provided was kept confidentially. Non-adherent patients during the study period were advised to return to the health facilities for a new assessment to avoid negative consequences from incomplete treatment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We received consent to present the results of our study in conferences, seminars, and to publish it in peer-reviewed journals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}